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DrFrankL.Hanley (Stanford, Calif).Congratulations, DrCarotti,
for a very nice presentation and congratulations to you and your
colleagues for an outstanding series.
Consensus regarding the management and outcomes of patients
with pulmonary atresia and collaterals has been hard to come by.
This study fromBambinoGesu´ Children’s Hospital adds to a grow-
ing international experience that is allowing some consensus to fi-
nally emerge. This study, along with other notable large series with
careful midterm follow-up, such as the 500-or-so plus cases from
the Stanford group and the roughly 300-or-so from the Birming-
ham, England, group, to name just a few, now provide an interna-
tional multiple center experience that is approaching 1000 cases or
more and provide a fairly clear picture regarding some very impor-
tant points with respect to this lesion.
The 3 major conclusions that I think we now pretty much have
a consensus on are the following:
First, when unifocalization is performed aggressively and rela-
tively early in life according to strict protocols coupled with intra-
cardiac repair, midterm outcomes can be achieved that improve
quite dramatically on the natural history of the disease.
Now, that might not sound like much of a comment. However, it
is notable that as recently as 5 to 10 years ago, and even up to this
present day, the question of whether surgery improves on the nat-
ural outcome has been seriously debated. Now, there is absolutely
no question that surgery improves the outcome.
I would go one step further and say that protocols such as yours,
which is very close to our protocol and quite close to, I think, Dr
Brawn’s protocol, also provide probably the best outcomes relative
to other alternative, competing surgical procedures.
The second point that I think we have a consensus on is that col-
lateral arteries when unifocalized correctly contribute importantly,
even critically, to a durable, growing, healthy pulmonary vascular
bed. Your excellent outcomes in this series with patients with com-
pletely absent native pulmonary arteries, that is, those patients
whose pulmonary vascular bed was reconstructed solely from
the collateral arteries, reflects our own program’s experience pretty
much exactly and underscores this point, that collaterals clearly
are very important.
The third major point is the following: ‘‘Tending the garden,’’ if
you will, that is, frequent assessment of, and surgery and catheter-
based management of, the reconstructed pulmonary vascular bed
are all extremely necessary parts of the long-term treatment of
these patients. Again, I think there is a growing consensus about
that.1100 The Journal of Thoracic and Cardiovascular SurThese points of consensus notwithstanding, many differences
remain in individual institutions with respect to the specifics of
the management protocols and the identification of the various
risk factors. Also, clearly, we cannot go into all of those nuances
and variations in this short period. I do want to focus on one area.
Your outcomes are outstanding. If you eliminated the one sub-
group, the mortality in the one subgroup (i.e., thosewho had under-
gone complete unifocalization and failed the flow study and did
not have VSD closure), if you eliminated the mortality, or equaled
the mortality, in that subgroup as in all your other subgroups, your
outcomes would be phenomenal. So that is where I want to focus.
I notice that you identified VSD closure as a risk factor for mor-
tality. In the 25 patients in that subgroup, complete unifocalization
without VSD closure, 6 patients died. I was wondering whether
you could say a few things about your insights into that subgroup
and specifically address the following questions:
When you do the flow study, what criteria for the flow study do
you use specifically to make that decision? Because that might af-
fect on why some of them were not doing well.
Second, and, perhaps, even more importantly, in this answer to
this question, how do you provide the pulmonary blood flow, be-
cause you were not closing the VSD? Do you use a shunt? Do
you use some form of right ventricle-pulmonary artery (RV-PA)
connection? Do you put a VSD patch on and then fenestrate it?
What are your thoughts on that?
Dr Carotti. Thank you very much for your comment and for
your questions.
Regarding the pulmonary flow study, we perform it exactly as
we learned from you in 1996 when we visited your center. We use
a derivation from the arterial port of the oxygenator to perfuse the
pulmonary vascular tree with oxygenated blood. We cool down
the patient to a nasopharyngeal temperature of 25C. We keep the
hematocrit at 25%. Then, with the heart beating, we perfuse
the pulmonary arterial tree by incremental steps up to 100%
of the cardiac index and record simultaneously the mean pulmo-
nary arterial pressure changes. We rely on a cutoff value of
30 mm Hg and decide to close the VSD as long as the mean
pulmonary arterial pressure remains within such a value. For
any pressure value exceeding 30 mm Hg, we leave the VSD un-
touched and provide pulmonary blood flow using a RV-PA con-
duit with the VSD left open. In a couple of patients with the
VSD left open, we banded the conduit because of a progressive
increase in the arterial oxygen saturation, to avoid overperfusion
of the pulmonary arterial bed.
We never perform primary closure of the VSD using a fenes-
trated patch. However, in our early experience, we had 2 patients
who developed hypersystemic right ventricular pressure after
VSD closure despite falsely reassuring pulmonary flow study find-
ings. In both cases, we decided to fenestrate the patch, and those
were the only patients who ended up with a fenestrated VSD patch
closure.
Regarding the use of a systemic pulmonary shunt, we did it once
in our very early experience by replacing the conduit originally im-
planted. However, that patient died. At the postmortem, she had
diffuse pulmonary vascular disease. She was a 12-year-old child.
After this unsuccessful experience, we have always preferred to
perform right ventricular outflow tract reconstruction to provide
blood flow to the lungs.gery c November 2010
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DDr Hanley. So I think I would summarize what I am getting
from your answer, that you do pretty much a standard flow study
with well-recognized parameters for deciding when to close
a VSD.
Just for the sake of argument, we, in our program, we never
open the right ventricle unless we are going to close the VSD.
Thus, everybody who fails a flow study receives a well-controlled
shunt, in an attempt to achieve a mean pressure of 25 mmHg in the
pulmonary arteries.
Now, I do not know whether that enters into why you had a 6 of
25 patient mortality. Not that that is terrible. I mean your results
overall are outstanding. But this is a sort of the hot spot where
you had a few little problems. We originally used RV-PA conduits
early in the game. By 2000, we had switched completely to shunts
when the flow study failed because we were having complications
with the systemic level RV-PA conduits and the ability to really
control the blood flow in the lungs really well.
Again, when creating a ventriculotomy, pulmonary insufficiency
is going to be present chronically and also pseudoaneurysms, et ce-
tera. All those thingswe found to be concerns. I do not knowwhether
the shunt makes the difference. It is a relatively small number and it
might not, but I am just pointing out some differences.
Dr Carotti. To corroborate what you say, in our experience,
a few patients with the VSD left open died because of massive pul-
monary hemorrhage, likely secondary to uncontrolled pulmonary
blood flow. In our mind, the most appealing reason to have an
RV-PA conduit providing forward flow is the optimal access for
percutaneous interventions, which might enhance the perspectives
of subsequent VSD closure. Actually, most of our patients who ex-
perienced massive pulmonary hemorrhage had chromosome
22q11 deletion, which remains an important risk factor for death
in our analysis, and we were more keen to correlate the airway
bleeding to the syndrome itself than to the uncontrolled pulmonary
blood flow. Anyway, I take your suggestion.
DrHanley. Then, a second very brief question. I noticed in your
manuscript, and I think in the presentation as well, the mean age at
which you performed unifocalization was 15 months. Now, I know
very well, as you do, when you are getting referrals, you cannot
control the patient’s age all the time. I also wonder whether that
slightly older age might have had something to do with some ofThe Journal of Thoracic and Carthose patients who had variable pulmonary blood flow with per-
haps slightly sick pulmonary microvascular systems because of
the long-term flow, up to 15 months. Again, the analogy I usually
make is you would never let a truncus go 15 months before you
would repair it. You know the patients are going to have pulmonary
vascular problems. I know you cannot control the age. Left in the
ideal situation, if you were referred a newborn, when would you
perform the unifocalization?
Dr Carotti. When the body weight is 5 kg.
Dr Sabine Daebritz (Duisburg, Germany). Thank you for this
very interesting talk.
Can you briefly comment on the criteria you used to decide
when to close the VSD once you had left it open.
Dr Carotti. Yes. Thank you first for your question.
We do rely only on the intraoperative pulmonary flow study and
on a mean pulmonary arterial pressure cutoff value of 30 mm Hg.
If we reach up to 30 mmHg for the mean pulmonary arterial blood
pressure during flow study, we go ahead and close the VSD. Other-
wise we leave the VSD open.
Dr Tweddell. I think she is asking, in those patients, when you
leave it open, when do you subsequently go back and close it?
Dr Carotti. I am sorry, I did not understand.
Usually, we restudy those patients about 12 months after the op-
eration and see what the pulmonary blood flow/systemic blood
flow (Qp/Qs) ratio is. In the absence of significant stenosis at the
distal anastomosis of the conduit, or at the unifocalization site,
we accept a Qp/Qs ratio greater than 1.5:1 to proceed with VSD
closure. Otherwise, we could accept an even lower Qp/Qs ratio
in the presence of significant stenoses, which would be treated at
operation.
What we learned from our most recent experience is that those
patients react during catheterization also to hyperoxia and nitrous
oxide administration. In the last couple of patients with a basic Qp/
Qs ratio of 1:1, hyperoxia increased the Qp/Qs ratio to 2:1 and ni-
trous oxide to 2.5:1. So we are also doing vasoreactivity functional
tests when we restudy such patients.
Dr Tweddell. When you do the flow study, what index do you
target?
Dr Carotti. 2.5 L/min/m2.
Dr Tweddell. Thank you very much.diovascular Surgery c Volume 140, Number 5 1101
